Daniel Jons

1.5k citations
21 papers · 1.1k · 1 hit paper · h-index 12

Impact in

  • Neurology top 2%
    • Myasthenia Gravis and Thymoma
    • Peripheral Neuropathies and Disorders
    • Parkinson's Disease and Spinal Disorders
    • Autoimmune Neurological Disorders and Treatments
    • Multiple Sclerosis Research Studies

Papers in

Daniel Jons

19 papers receiving 1.1k citations

Daniel Jons's Hit Papers

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017 · 622 citations
6220+3+6Years since publication200400600

Peers

Daniel Jons
Comparison fields: 5 of 62
  • Neurology 723
  • Pathology and Forensic Medicine 189
  • Infectious Diseases 129
  • Immunology 135
  • Oncology 85
Replace Kerry Naunton with:
Kerry Naunton United States
Laura Fionda Italy
Sascha Alvermann Germany
Lech Szczechowski United States
Jana Junkerová Czechia
Tomoko Tsuda Japan
Akiko Nagaishi Japan
Rekha Pillai United States
Ali Malekniazi Iran
Alan Ross Berger United States
Daniel Jons relative to Kerry Naunton United States Kerry Naunton's profile →
Citations per field
00.5×1.5×2.2×
Kerry Naunton · 1×
Citations per year

Countries citing papers authored by Daniel Jons

Since Specialization
Citations

This map shows the geographic impact of Daniel Jons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Jons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Jons more than expected).

Fields of papers citing papers by Daniel Jons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Jons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Jons. The network helps show where Daniel Jons may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Jons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Jons Line = papers co-authored together Daniel Jons links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Hit paper breakdown →
2017622
2 2022130
3 201966
4 202045
5 202145
6 202143
7 202220
8 202020
9 202319
10 201718
11 201916
12 201414
13 202311
14 202110
15 20228
16 20225
17 20244
18 20204
19 20164
20 20250

About Daniel Jons

Daniel Jons is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Epidemiology and Immunology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (8 papers), Myasthenia Gravis and Thymoma (6 papers), Cytomegalovirus and herpesvirus research (4 papers), Polyomavirus and related diseases (4 papers), Herpesvirus Infections and Treatments (3 papers), Viral-associated cancers and disorders (2 papers), Peripheral Neuropathies and Disorders (2 papers) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Neurology (723 citations), Pathology and Forensic Medicine (189 citations), Infectious Diseases (129 citations), Immunology (135 citations) and Oncology (85 citations). Daniel Jons has collaborated with scholars based in Sweden, Germany and United Kingdom. Frequent co-authors include Peter Sundström, Oluf Andersen, Martin Gunnarsson, Martin Biström, Magnus Vrethem, Lucía Alonso-Magdalena, Johan Hultdin, Henrik Zetterberg, Kaj Blennow and Ingrid Skelton Kockum. Their work appears in journals such as European Journal of Neurology, Acta Neurologica Scandinavica, Journal of Neuroimmunology, Neurology and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact